<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83687">
  <stage>Registered</stage>
  <submitdate>9/03/2009</submitdate>
  <approvaldate>22/05/2009</approvaldate>
  <actrnumber>ACTRN12609000328279</actrnumber>
  <trial_identification>
    <studytitle>The prevention of colds and flus with Echinacea for long economy flights</studytitle>
    <scientifictitle>Investigations into the effectiveness of a standardised Echinacea preparation in preventing colds, flus and other respiratory disorders for air-travellers on long economy flights</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>airline travel related colds, flus and other respiratory disorders</healthcondition>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Herbal remedies</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Normal development and function of the immune system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention tablets contain 675mg herb equivalent of Echinacea purpurea and 600mg herb equivalent of Echinacea angustifolia.  Participants will take 1 tablet twice a day for 2 weeks prior to travel, 2 tablets twice a day when flying, 1 tablet twice a day during their time away.  If the participant experiences symptons of a cold or flu, they will take 3 tablets twice a day for a maximum of 4 days before returning to the normal 1 tablet twice a day dose.</interventions>
    <comparator>Placebo tablets are appearance matched using maltodextrin, povidone and permicol brown colour to simulate the missing echinacea.  All other excipients are the same. Dosing and duration will be the same as for the intervention treatment arm.</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>A decrease in travel related colds, flus and other respiratory disorders.</outcome>
      <timepoint>Participants will keep a daily diary on their health status from 2 weeks prior to departure, during their travels and for 2 weeks after they return home.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>nil</outcome>
      <timepoint>nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>travel via economy class from Australia to Europe or North America

travel period is between 2 and 4 weeks

Participants must be in good health with no colds in the 2 weeks before they start the trial</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>pollen/plant allergy
lactation or pregnancy
diagnosed respiratory disease</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>blinding and randomisation has already occurred.  Patients will just be allocated the next patient number and the tablets associated with that number.  Patient numbers and tablets were allocated off-site by the sponsor</concealment>
    <sequence>use of a website that randomises treatments when given the number of partients and the protocol.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>9/03/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>MediHerb Pty Ltd</primarysponsorname>
    <primarysponsoraddress>3/85 Brandl St
Eight Mile Plains
Queensland 4113</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>MediHerb Pty Ltd</fundingname>
      <fundingaddress>3/85 Brandl St
Eight Mile Plains
Queensland 4113</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>AusIndustry Commercial Ready Grant</fundingname>
      <fundingaddress>Department of Innovation, Industry, Science and Research
Level 12, 100 Creek St, Brisbane, QLD 4000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>MediHerb Pty Ltd</fundingname>
      <fundingaddress>3/85 Brandl St, Eight Mile Plains, Queensland 4113</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>New secondary sponsor name. Please modify.</sponsorname>
      <sponsoraddress>New secondary sponsor address. Please modify.</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Echinacea has shown immuno-modulating effects and this study will investigate the efficacy of an echinacea preparation in the prevention of respiratory and other symptoms associated with air travel.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Griffith University Human Research Ethics Committee</ethicname>
      <ethicaddress>Office for Research, Bray Centre (N54), Nathan Campus, Griffith University
170 Kessels Road, Nathan, Queensland 4111</ethicaddress>
      <ethicapprovaldate>17/12/2008</ethicapprovaldate>
      <hrec>PHM/06/08HREC</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Evelin Tiralongo</name>
      <address>School of Pharmacy
Griffith University
Gold Coast Campus
Queensland 4222</address>
      <phone>+61 7 5552 7098</phone>
      <fax />
      <email>e.tiralongo@griffith.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Shirley Wee</name>
      <address>Genomics Research Centre Clinic
Griffith University
Southport
Queensland 4222</address>
      <phone>+61 7 5552 9773</phone>
      <fax />
      <email>s.wee@griffith.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Anita Matthias</name>
      <address>3/85 Brandl St
Eight Mile Plains
Queensland 4113</address>
      <phone>+61 7 3423 6524</phone>
      <fax />
      <email>anita.matthias@mediherb.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>